Get access

A polymorphism linked to RRAS, SCAF1, IRF3 and BCL2L12 genes is associated with cirrhosis in hepatitis C virus carriers

Authors

  • Luis M. Real,

    Corresponding author
    1. Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
    2. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain
    • Correspondence

      Luis Miguel Real, Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Avda. de Bellavista. 41014 Sevilla. Spain

      Tel: +34 9 5501 5684

      Fax: +34 9 5501 5795

      e-mail: lmreal67b@gmail.com

    Search for more papers by this author
  • Antonio Caruz,

    1. Unidad de Inmunogenética, Universidad de Jaén, Jaén
    Search for more papers by this author
  • Antonio Rivero-Juarez,

    1. Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, Spain
    2. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), Córdoba, Spain
    Search for more papers by this author
  • Vicente Soriano,

    1. Departamento de Enfermedades Infecciosas, Hospital Carlos III, Madrid, Spain
    Search for more papers by this author
  • Karin Neukam,

    1. Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
    2. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain
    Search for more papers by this author
  • Antonio Rivero,

    1. Unidad de Enfermedades Infecciosas, Hospital Universitario Reina Sofía, Córdoba, Spain
    2. Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBC), Córdoba, Spain
    Search for more papers by this author
  • Celia Cifuentes,

    1. Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
    2. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain
    Search for more papers by this author
  • José A. Mira,

    1. Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
    2. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain
    Search for more papers by this author
  • Juan Macías,

    1. Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
    2. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain
    Search for more papers by this author
  • Juan A. Pineda

    1. Unidad de Enfermedades Infecciosas y Microbiología, Hospital Universitario de Valme, Sevilla, Spain
    2. Instituto de Biomedicina de Sevilla (IBIS), Sevilla, Spain
    Search for more papers by this author

Abstract

Background & Aims

Host genetic factors could play a primary role in determining risk for cirrhosis development in HCV-infected patients. The aims of this study were to discover new genetic variants associated with this trait and to replicate some associations formerly reported.

Methods

Three hundred and thirty-seven HCV carriers with available data about liver fibrosis status, who initiated treatment with pegylated interferon plus ribavirin, were included. Of them, 77 (22.85%) were cirrhotic. One hundred and forty-four SNPs from 40 genes related to cholesterol metabolism/transport, sustained viral response to HCV therapy, liver fibrosis, or immune response, were genotyped in all samples. Plink software was used to perform univariate association analyses. The results obtained were adjusted by other parameters related to cirrhosis using multivariate logistic regression models.

Results

Only the SNP rs12104272, linked to RRAS, SCAF1, IRF3 and BCL2L12 genes, was associated with cirrhosis. It was observed a higher proportion of rs12104272 A allele carriers in the non-cirrhotic group (60.63%) than in the cirrhotic group (38.15%) (adjusted OR = 0.36, 95% CI = 0.180-0.746, P = 0.006). This effect was stronger in the background of rs12979860 CC genotype of IL28B (adjusted OR = 0.069, 95% CI = 0.014–0.349, P = 0.001).

Conclusion

The rs12104272 SNP could have clinical value to select those individuals at lower risk for cirrhosis development.

Ancillary